Puma Biotechnology, Inc.
Clinical trials sponsored by Puma Biotechnology, Inc., explained in plain language.
-
New combo therapy aims to control advanced breast cancer
Disease control Recruiting nowThis study tests a drug called alisertib combined with hormone therapy for people with a common type of advanced breast cancer (HR+, HER2-). The goal is to find the best dose and see if the combination can shrink tumors or slow the disease. About 150 adults whose cancer has worse…
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
New hope for tough lung cancer: targeted drug alisertib under study
Disease control Recruiting nowThis study tests an experimental drug called alisertib in people with advanced small cell lung cancer whose disease has worsened after standard treatments. About 80 adults will receive alisertib alone to see if it can shrink tumors or slow the cancer. Researchers will also look f…
Phase: PHASE2 • Sponsor: Puma Biotechnology, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC